Bon Secours Cancer Institute at DePaul Recognized

Commission on Cancer of the American College of Surgeons Provides Three-year Re-accreditation

Bon Secours Cancer Institute at DePaul announced today the Commission on Cancer of the American College of Surgeons has granted a three-year re-accreditation.  The cancer services are designated as a Comprehensive Community Cancer Program.  

To earn the three-year accreditation, a cancer program must meet more than 30 Commission on Cancer quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care.

“Our mission at Bon Secours Cancer Institute at DePaul is to improve the overall health of the communities that we serve,” said Charles Ives, MD, FACS, general surgeon with Bon Secours Surgical Specialists and the cancer institute’s Commission on Cancer liaison. “We appreciate the recognition from the Commission on Cancer of the American College of Surgeons and the dedication of all our team members who strive to live that mission every day.”

The CoC Accreditation Program encourages hospitals, treatment centers, and other facilities to improve their quality of patient care through various cancer-related programs. These programs focus on prevention, early diagnosis, pretreatment evaluation, staging, optimal treatment, rehabilitation, surveillance for recurrent disease, support services, and end-of-life care.  Recognizing that cancer is a complex group of diseases, the CoC Cancer Program Standards promote consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists. This multidisciplinary cooperation results in improved patient care.

There are currently more than 1,500 CoC-accredited cancer programs in the United States and Puerto Rico, representing 30 percent of all hospitals.